Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Allegiance Research Specialists
1724
mi
from 91732
Wauwatosa, WI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Allegiance Research Specialists
1724
mi
from 91732
Wauwatosa, WI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
GI Associates
1722
mi
from 91732
Wauwatosa, WI
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
GI Associates
1722
mi
from 91732
Wauwatosa, WI
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Nepean Public Hospital
7534
mi
from 91732
Kingswood,
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Nepean Public Hospital
7534
mi
from 91732
Kingswood,
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Shands Endoscopy Center
2105
mi
from 91732
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Shands Endoscopy Center
2105
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Shands Hospital at the University of Florida
2103
mi
from 91732
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Shands Hospital at the University of Florida
2103
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Investigational Drug Service
mi
from 91732
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Investigational Drug Service
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Shands Medical Plaza and Cancer Center
2104
mi
from 91732
Gainesville, FL
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Shands Medical Plaza and Cancer Center
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Digestive and Liver Disease Specialists
2341
mi
from 91732
Norfolk, VA
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Digestive and Liver Disease Specialists
2341
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated:  9/12/2017
Christus Trinity Mother Frances Endoscopy Center
1316
mi
from 91732
Tyler, TX
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Christus Trinity Mother Frances Endoscopy Center
1316
mi
from 91732
Tyler, TX
Click here to add this to my saved trials
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
Status: Enrolling
Updated:  9/12/2017
Nebraska Medical Center
1289
mi
from 91732
Omaha, NE
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
Status: Enrolling
Updated: 9/12/2017
Nebraska Medical Center
1289
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study
Status: Enrolling
Updated:  9/13/2017
UNC Center for Functional GI and Motility Disorders
2195
mi
from 91732
Chapel Hill, NC
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study
Status: Enrolling
Updated: 9/13/2017
UNC Center for Functional GI and Motility Disorders
2195
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
Randomized Control Trial Evaluating Optimal Patient Turning Procedures for Reducing Hospital Acquired Pressure Ulcers
Status: Enrolling
Updated:  9/13/2017
Stanford Health Care
328
mi
from 91732
Stanford, CA
Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
Randomized Control Trial Evaluating Optimal Patient Turning Procedures for Reducing Hospital Acquired Pressure Ulcers
Status: Enrolling
Updated: 9/13/2017
Stanford Health Care
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Postoperative Pain After Pediatric Umbilical Hernia Repair
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated:  9/14/2017
Children's Hospital Boston
2576
mi
from 91732
Boston, MA
Postoperative Pain After Pediatric Umbilical Hernia Repair
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated: 9/14/2017
Children's Hospital Boston
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Postoperative Pain After Pediatric Umbilical Hernia Repair
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated:  9/14/2017
Children's Hospital Boston at Waltham
2568
mi
from 91732
Waltham, MA
Postoperative Pain After Pediatric Umbilical Hernia Repair
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated: 9/14/2017
Children's Hospital Boston at Waltham
2568
mi
from 91732
Waltham, MA
Click here to add this to my saved trials
The North American Pancreatitis Study
The North American Pancreatitis Study
Status: Enrolling
Updated:  9/14/2017
University of Pittsburgh
2121
mi
from 91732
Pittsburgh, PA
The North American Pancreatitis Study
The North American Pancreatitis Study
Status: Enrolling
Updated: 9/14/2017
University of Pittsburgh
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated:  9/14/2017
Radiant Research, Inc.
352
mi
from 91732
Tempe, AZ
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Radiant Research, Inc.
352
mi
from 91732
Tempe, AZ
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated:  9/14/2017
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Cleveland Clinic
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated:  9/14/2017
TFS
mi
from 91732
Søborg,
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
TFS
mi
from 91732
Søborg,
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated:  9/14/2017
Prism research center
1512
mi
from 91732
Saint Paul, MN
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Prism research center
1512
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated:  9/14/2017
OhioHealth Riverside Methodist Hospital
1959
mi
from 91732
Columbus, OH
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated: 9/14/2017
OhioHealth Riverside Methodist Hospital
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
Baptist Clinical Research
1809
mi
from 91732
Pensacola, FL
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Baptist Clinical Research
1809
mi
from 91732
Pensacola, FL
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
The Care Group, LLC
1792
mi
from 91732
Indianapolis, IN
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
The Care Group, LLC
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
Boston Med Ctr
2577
mi
from 91732
Boston, MA
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Boston Med Ctr
2577
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
Dartmouth Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Dartmouth Hitchcock Medical Center
2515
mi
from 91732
Lebanon, NH
Click here to add this to my saved trials
Dietary Soy Isoflavones In Chronic Pancreatitis
Dietary Soy Isoflavones In Chronic Pancreatitis
Status: Enrolling
Updated:  9/18/2017
Philip Hart
1959
mi
from 91732
Columbus, OH
Dietary Soy Isoflavones In Chronic Pancreatitis
Dietary Soy Isoflavones In Chronic Pancreatitis
Status: Enrolling
Updated: 9/18/2017
Philip Hart
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated:  9/18/2017
Brooke Army Medical Center
1190
mi
from 91732
Fort Sam Houston, TX
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
Brooke Army Medical Center
1190
mi
from 91732
Fort Sam Houston, TX
Click here to add this to my saved trials
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated:  9/18/2017
Gastroenterology Consultants of San Antonio
1192
mi
from 91732
Live Oak, TX
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
Gastroenterology Consultants of San Antonio
1192
mi
from 91732
Live Oak, TX
Click here to add this to my saved trials
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated:  9/18/2017
Fundación de Investigación
3358
mi
from 91732
San Juan,
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
Fundación de Investigación
3358
mi
from 91732
San Juan,
Click here to add this to my saved trials
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
Prevention of Relapse to Opioid Addiction Using Depot Naltrexone
Status: Enrolling
Updated:  9/21/2017
Treatment Research Center
2373
mi
from 91732
Philadelphia, PA
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
Prevention of Relapse to Opioid Addiction Using Depot Naltrexone
Status: Enrolling
Updated: 9/21/2017
Treatment Research Center
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
2105
mi
from 91732
Gainesville, FL
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
2105
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  9/21/2017
GSK Investigational Site
2186
mi
from 91732
Orlando, FL
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 9/21/2017
GSK Investigational Site
2186
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Stanford University
329
mi
from 91732
Palo Alto, CA
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Stanford University
329
mi
from 91732
Palo Alto, CA
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Yale University
2486
mi
from 91732
New Haven, CT
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Yale University
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Emory University
1919
mi
from 91732
Atlanta, GA
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Indiana University
1791
mi
from 91732
Indianapolis, IN
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Indiana University
1791
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Iowa
1527
mi
from 91732
Iowa City, IA
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Iowa
1527
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Wayne State University
1965
mi
from 91732
Detroit, MI
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Wayne State University
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Rochester
2244
mi
from 91732
Rochester, NY
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Rochester
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Wake Forest University
2129
mi
from 91732
Charlotte, NC
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Wake Forest University
2129
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
RTI International
2204
mi
from 91732
Durham, NC
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
RTI International
2204
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Duke University
2203
mi
from 91732
Durham, NC
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Duke University
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Cincinnati Children's Medical Center
1880
mi
from 91732
Cincinnati, OH
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Cincinnati Children's Medical Center
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Case Western Reserve University, Rainbow Babies and Children's Hospital
2036
mi
from 91732
Cleveland, OH
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Case Western Reserve University, Rainbow Babies and Children's Hospital
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
Brown University, Women & Infants Hospital of Rhode Island
2562
mi
from 91732
Providence, RI
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Brown University, Women & Infants Hospital of Rhode Island
2562
mi
from 91732
Providence, RI
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
UT Southwestern Medical Center
1221
mi
from 91732
Dallas, TX
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
UT Southwestern Medical Center
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated:  9/22/2017
University of Utah
572
mi
from 91732
Salt Lake City, UT
Early-Onset Sepsis Surveillance Study
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials